Related Experiment Video
Updated: Mar 17, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Thrombolytic treatment in a patient with antiphospholipid syndrome : APS developing renal infarction
1Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Suleyman Demirel University, Ayazmana Mah., 4419. Cad. Metro City Vadi Evleri D Blok Daire: 16, 32000, Isparta, Turkey. dryunusugan@hotmail.com.
Abstract:
Antiphospholipid syndrome (APS), a leading entity in acquired thrombophilia, is characterized by recurrent thrombosis, morbidity in pregnancy and presence of antiphospholipid antibodies (APA). Although the etiopathogenesis is unclear, APA against negatively charged phospholipids and phospholipid-protein complexes are held responsible for the clinical picture. In case of acute thrombosis due to APS, thrombolytic therapy is not a commonly administered treatment option. Here, we present a case with acute thrombosis in the left renal artery showing partial response to thrombolytic therapy.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism III: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care

